1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)

The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)

  • January 2015
  • -
  • Kalorama Information
  • -
  • 344 pages

Summary

Table of Contents

Search Inside

The maturation of IVD markets in developed countries has IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new health consciousness population with growing demands for quality medical care. Latin America (LATAM) is a key target for IVD manufacturers. Kalorama Information, working in conjunction with Argentina-based VA Consultadora y Asociados, has developed a superior resource for business planners in the IVD industry considering emerging markets.

Detailed Country-by-Country Analysis of the In Vitro Diagnostic Markets of Latin America

Each country in Latin America has its own healthcare system, insurance system, regulations and competitive situation. To be useful, a report must provide a country-level analysis. This Kalorama Information report focuses on the market for reagents and instruments in the most important countries of the continent. Brazil, Chile, Colombia, Peru and Argentina are singled out for a deeper level of analysis. Uruguay, Venezuela, Ecuador and other nations are also considered. For the main country market analysis, the following data are presented:

Brazil: IVD Market and Forecast, Market Share, Insurance Statistics, Brazilian Labs Data, Brazilian Blood Bank Data Segment markets for: Clinical Chemistry, POC, Glucose, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Molecular Microbiology, Nucleic Acid Test, Flow Cytometry, Cardiac Markers

Colombia: IVD Market and Forecast, Market Share, Insurance Statistics, Colombian Labs Data and Blood Bank Statistics Segment Markets for Clinical Chemistry, Emergency, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Moleuclar Microbiology, Molecular Non Infectious Disease, Flow Cytometry, Cardiac Markers.

Chile: IVD Market and Forecast, Market Share, Insurance Statistics, Chilean Labs Data and Blood Bank Statistics. Segment Markets for Clinical Chemistry, Emergency, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Moleuclar Microbiology, Molecular Non Infectious Disease, Flow Cytometry, Cardiac Markers

Argentina: IVD Market and Forecast, Market Share, Insurance Statistics, Argentinean Labs Data and Blood Bank Statistics. Segment Markets for Clinical Chemistry, Emergency, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Moleuclar Microbiology, Molecular Non Infectious Disease, Flow Cytometry, Cardiac Markers.

Peru: IVD Market and Forecast, Market Share, Insurance Statistics, Peruvian Labs Data and Blood Bank Statistics. Segment Markets for Clinical Chemistry, Emergency, Hematology, Immunoassays, Immunoassays Microbiology, Coagulation, Urinalysis, Microbiology, Moleuclar Microbiology, Molecular Non Infectious Disease, Flow Cytometry, Cardiac Markers)

Top level IVD markets and forecasts are provided for Ecuador, Venezuela, Uruguay and Other LATAM. The report also contains competitor profiles, population and economic statistics, country market comparisons and analyst conclusions.

Superior Market Share Analysis: Significant Country and Segment Shares

While Latin America is a recognized opportunity for major IVD competitors, it is a familiar region for many as well. Major firms have been in Brazil for decades. Competition in these countries. But each country has its own competitive dynamics. Different companies lead in different segments of testing in this countries. A leader in Argentina may not be in Colombia and so on and so forth. Kalorama illuminates these differences with market share for each major nation in the region. In many cases, where it can be reliably determined, Kalorama provides segment level market share by-country.

Segment-level Market Sizing

Know the market opportunity for the area of IVD that you compete in or invest in. Kalorama Information's proprietary market sizing provides knowledge of the total manufacturer earnings in a given market within each major country. The segments under analysis include reagents, consumables, calibrators and controls of the
following sub-segments: Clinical Chemistry, Hematology, Immunology, Microbiology Immunoassays, Coagulation, Blood Banking, Urinalysis, Microbiology, Molecular Microbiology, Nucleic Acid Testing, Flow Cytometry, Primary Staining Histology, Advanced Staining Histology, Cardiac Markers.

Kalorama Information only publishes reports in healthcare and specializes in IVD with subspecialties in biotechnology and devices. Kalorama is the publisher of the Worldwide Market for In Vitro Diagnostics. In nine editions, it is used by major IVD companies for their business development and planning efforts. Kalorama now applies its method to the Latin American market €“ secondary research into company financial statements, medical and government literature, combined with primary research (interviews) with distributors, manufacturers and end users. This research is then considered by an experienced analyst. In this effort, Kalorama has partnered with VA Consultora, a recognized market research and laboratory survey company in Buenos Aires, Argentina with networks of IVD market watchers in every major Latin American capital.

Detailed Competitive Analysis

There is robust competition in the Latin American IVD market. Knowing who is in the market will enable business executives to understand and benchmark their efforts and also provide models for success in the market. This report cites the key competitors in each country and their main strengths. Companies Analyzed in the report include.

Abbott
Albis
Andina Medica
Becton Dickinson
Belomed SRL
Biomed
Bio-Rad
BioTechnica
Biomedical Systems
Biomerieux
Diagnostica Peruana
Diamed Argentina
DiaSorin
Farmalatina Ltda
Felsan SA
Galenica
Gematec
Grifols Chile S.A
Horiba ABX
Ortho-Clinical Diagnostics .
Qiagen
Wama
Wiener Lab/Labinbraz
Jampar Multiplest Internacional
Johnson & Johnson
Labin Peru
Labin Wiener
Medicatec SRL
Tecnigen S.A.
Química Suiza S.A.
Representaciones Medicas del Peru S.R. Ltda.
Roche Diagnostics
Siemens Healthcare
WM Argentina

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2017 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • March 2017
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Point-of-care Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Point-of-care Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Point-of-Diagnostics Market: Overview Point-of-care diagnostics is carried out in the clinics, home or near patient locations for testing of a sample from a patient in order to facilitate a prompt ...

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

  • $ 5000
  • Industry report
  • February 2017
  • by Future Market Insight Global & Consulting Pvt Ltd

With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.